• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Targeted inhibition of gut microbiota proteins involved in TMAO production to reduce platelet aggregation and arterial thrombosis: a blueprint for drugging the microbiota in the treatment of cardiometabolic disease?

作者信息

van Mens T E, Büller H R, Nieuwdorp M

机构信息

Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.

Departments of Internal Medicine, Amsterdam Diabetes Center, Amsterdam University Medical Centers, AMC and VUMc, Amsterdam, the Netherlands.

出版信息

J Thromb Haemost. 2019 Jan;17(1):3-5. doi: 10.1111/jth.14331. Epub 2018 Dec 10.

DOI:10.1111/jth.14331
PMID:30548165
Abstract
摘要

相似文献

1
Targeted inhibition of gut microbiota proteins involved in TMAO production to reduce platelet aggregation and arterial thrombosis: a blueprint for drugging the microbiota in the treatment of cardiometabolic disease?靶向抑制参与氧化三甲胺生成的肠道微生物群蛋白质以减少血小板聚集和动脉血栓形成：治疗心脏代谢疾病时对微生物群进行药物干预的蓝图？
J Thromb Haemost. 2019 Jan;17(1):3-5. doi: 10.1111/jth.14331. Epub 2018 Dec 10.
2
Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk.黄素单加氧酶 3 是机体三甲基胺 N-氧化物生成途径中的主要肝酶，可调节血小板反应性和血栓形成风险。
J Thromb Haemost. 2018 Sep;16(9):1857-1872. doi: 10.1111/jth.14234. Epub 2018 Aug 9.
3
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk.肠道微生物代谢产物氧化三甲胺增强血小板高反应性和血栓形成风险。
Cell. 2016 Mar 24;165(1):111-124. doi: 10.1016/j.cell.2016.02.011. Epub 2016 Mar 10.
4
Targeting the human microbiome and its metabolite TMAO in cardiovascular prevention and therapy.靶向人类微生物组及其代谢产物氧化三甲胺用于心血管疾病的预防和治疗。
Pharmacol Ther. 2020 Sep;213:107584. doi: 10.1016/j.pharmthera.2020.107584. Epub 2020 May 22.
5
The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases.肠道微生物代谢产物三甲胺 N-氧化物与心血管疾病。
Front Endocrinol (Lausanne). 2023 Feb 7;14:1085041. doi: 10.3389/fendo.2023.1085041. eCollection 2023.
6
Vascular endothelial tissue factor contributes to trimethylamine N-oxide-enhanced arterial thrombosis.血管内皮组织因子促进三甲胺 N-氧化物增强的动脉血栓形成。
Cardiovasc Res. 2022 Jul 27;118(10):2367-2384. doi: 10.1093/cvr/cvab263.
7
Microbial Transplantation With Human Gut Commensals Containing CutC Is Sufficient to Transmit Enhanced Platelet Reactivity and Thrombosis Potential.含有 CutC 的人类肠道共生微生物移植足以传递增强的血小板反应性和血栓形成潜力。
Circ Res. 2018 Oct 26;123(10):1164-1176. doi: 10.1161/CIRCRESAHA.118.313142.
8
[Gut microbiota and its metabolite trimethylamine-N-oxide (TMAO): a novel regulator in coronary artery disease].[肠道微生物群及其代谢产物氧化三甲胺（TMAO）：冠状动脉疾病中的一种新型调节因子]
Sheng Wu Gong Cheng Xue Bao. 2021 Nov 25;37(11):3745-3756. doi: 10.13345/j.cjb.210292.
9
Targeted Inhibition of Gut Microbial Trimethylamine N-Oxide Production Reduces Renal Tubulointerstitial Fibrosis and Functional Impairment in a Murine Model of Chronic Kidney Disease.靶向抑制肠道微生物三甲胺 N-氧化物生成可减少慢性肾脏病小鼠模型的肾间质纤维化和功能障碍。
Arterioscler Thromb Vasc Biol. 2020 May;40(5):1239-1255. doi: 10.1161/ATVBAHA.120.314139. Epub 2020 Mar 26.
10
Trimethylamine -oxide: heart of the microbiota-CVD nexus?氧化三甲胺：肠道菌群与 CVD 关联的核心？
Nutr Res Rev. 2021 Jun;34(1):125-146. doi: 10.1017/S0954422420000177. Epub 2020 Jul 28.

引用本文的文献

1
Progression of atherosclerosis with carnitine supplementation: a randomized controlled trial in the metabolic syndrome.补充肉碱对动脉粥样硬化进展的影响：一项针对代谢综合征的随机对照试验
Nutr Metab (Lond). 2022 Apr 2;19(1):26. doi: 10.1186/s12986-022-00661-9.
2
TMAO and Gut Microbial-Derived Metabolites TML and γBB Are Not Associated with Thrombotic Risk in Patients with Venous Thromboembolism.氧化三甲胺及肠道微生物衍生代谢物TML和γ-丁基甜菜碱与静脉血栓栓塞症患者的血栓形成风险无关。
J Clin Med. 2022 Mar 4;11(5):1425. doi: 10.3390/jcm11051425.
3
TMAO: a potential mediator of clopidogrel resistance.
氧化三甲胺（TMAO）：一种潜在的氯吡格雷抵抗的介体。
Sci Rep. 2021 Mar 22;11(1):6580. doi: 10.1038/s41598-021-85950-8.
4
Systems biology in cardiovascular disease: a multiomics approach.心血管疾病中的系统生物学：一种多组学方法。
Nat Rev Cardiol. 2021 May;18(5):313-330. doi: 10.1038/s41569-020-00477-1. Epub 2020 Dec 18.
5
Gut Microbiota-Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target.肠道微生物群依赖的标志物氧化三甲胺在促进心血管疾病中的作用：炎症机制、临床预后及作为治疗靶点的潜力
Front Pharmacol. 2019 Nov 19;10:1360. doi: 10.3389/fphar.2019.01360. eCollection 2019.